A Study to Evaluate the Tolerability, Safety, Pharmacokinetics, and Antitumor Activity of Loncastuximab Tesirine in Combination With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated Diffuse Large B-cell Lymphoma (LOTIS-8)
Clinical trial NCT04974996 · WITHDRAWN
Trial details
- NCT number
- NCT04974996
- Sponsor
- ADC Therapeutics S.A.
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-01
- Primary completion
- 2024-03-11
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.